Ten trillion yuan to support the "healthy China" strategy, the health and Family Planning Commission launched the preparation of "healthy China Construction Plan (2016-2020)"

Source: Bio exploration 2015-10-27 according to the national health literacy promotion action plan (2014-2020) issued by the health plan, the basic health literacy level of Chinese residents was 6.48% in 2008 and 8.80% in 2012, which is at a relatively low level It is expected to reach 10% in 2015 and 20% in 2020 After putting forward the construction of "beautiful China", the strategy of "healthy China" is coming out At the beginning of September, the national health and Family Planning Commission has launched the preparation of "healthy China Construction Plan (2016-2020)" According to the statistics of health industry's 100 billion luxury cake, the proportion of health industry in the United States accounts for more than 15% of GDP, that in Canada and Japan accounts for more than 10% of GDP, and that in China only accounts for 4% to 5% of GDP With the implementation of "healthy China" strategy, the medical and health industry focusing on big health, big health and big medicine is expected to break through 10 trillion market scale during the 13th Five Year Plan period, and the medical and health industry will also lead a new round of economic development wave Li Bin, director of the national health and Family Planning Commission, pointed out that the strategic plan will focus on people's health, implement the "healthy China" strategy and integrate it into the economic and social development, and achieve the health development goals through comprehensive policies and measures "Healthy China" strategy has been brewing for many years As early as the 2007 annual meeting of China Association for science and technology, Chen Zhu, then Minister of health, announced the three-step strategy of "health care well-off, well-off health" In August 2012, the Ministry of health organized hundreds of experts to discuss and finally form the "healthy China 2020" strategic research report, which was put forward to 2020 In, the basic medical and health system covering urban and rural residents was improved, and everyone could enjoy basic medical and health services The level of medical security was continuously improved, and the utilization of health services was significantly improved The health difference among people in different regions was further reduced, and the national health level reached the level of moderately developed countries Big health industry has become the largest emerging industry in the world People's income level has increased People's wealth and wealth have come out The emergence of chronic diseases makes people have to pay attention to physical exercise, as well as related goods and services People's expenditure on health-related consumption is obvious, and the growth rate is faster than that of consumer goods, so health consumption will become the focus of the whole society; on the other hand, China's economy is in the period of transformation and upgrading, the traditional investment pulling mode is difficult to sustain, and the consumption upgrading is urgently needed to drive the new economic growth, and medical consumption is the most important part Residents have a strong demand for health consumption, the population structure is deeply aging, and the demand for the elderly is more vigorous From the perspective of supply, countries with insufficient health services from the perspective of industrial development, consumption has become the first driving force for economic growth, and consumption is facing upward pressure In this case, cultivate new consumption growth points, and health consumption has become a field worthy of attention Classification of health industry in China The development of China's health industry has entered the normal state of the two systems of medical and non-medical health services going hand in hand Under the general pattern, a number of industrial chains have been formed, including the medical industry with the medical service institutions as the main body, the medical industry with the production and sale of drugs, equipment and consumables as the main body, and the health care industry with the production and sale of health care and health products as the main body Industry, health management service industry with personalized health testing consultation and conditioning guarantee service as the main body Among them, the scope of health industry in the field of biotechnology mainly includes basic research of life science, disease prevention research, diagnostic research, treatment research, surgery, instruments, drugs, newborn health research, fertility research, Genealogy Research, etc The development of health industry conforms to the trend of the times and vigorously develops health industry, which helps us to optimize resources, guide social capital and other resources to gather and enter the field of health industry, and resist external pressure from localized innovation Data statistics show that China has entered an aging society since 2000 At present, the proportion of the elderly aged 65 and above in China is close to 10% The high incidence of diseases in the elderly (three high, Parkinson's disease, Alzheimer's disease and other neurological diseases) is increasing, and the treatment cycle of cancer, AIDS, cardiovascular and cerebrovascular diseases is long and the cost is high In recent years, influenza and other new infectious diseases are frequent, environmental pollution, occupational stress, local diseases and other problems still exist The development of health industry will be beneficial to the reform of medical and health system and meet the health problems and challenges Listed companies have begun to seize the beach and increase the size of health industry At the time of the state's intensive planning of "healthy China" strategy, some listed companies with keen business sense have begun to seize the beach and add to the health industry In addition to the leading domestic innovative drug enterprises such as Hengrui pharmaceutical and Junshi biology, the new drug trend oriented enterprises such as sibyman, Beilu pharmaceutical, Xiangxue pharmaceutical, Yinhe investment, etc (tumor immunotherapy); cro / CMO Leading Taige pharmaceutical, boten Co., Ltd., Jiuzhou pharmaceutical, etc.; Kehua biological, lipang instrument, Mindray medical and Mike biological with strong R & D and innovation ability and high-end product positioning in equipment enterprises; sannuo biological, Hejia shares and baolaite with diversified product reserves and abundant funds available; Runda medical with novel model and in line with the general direction of medical reform; elderly care and chronic disease management In addition to Furui, Wanda information, Aier Ophthalmology, Dean diagnostics, etc., there are some enterprises outside the industry that are also laying out large health industry For example, Wanrun Co., Ltd., which is engaged in the R & D, production and sales of TFT liquid crystal intermediates and liquid crystal monomers, announced in October to acquire all the equity of mpbiomedicals, an American life science and in vitro diagnostics company, with a total of 1.03 billion yuan, to firmly transform and upgrade, and enter the field of life science and in vitro diagnostics Shen Shuguang, vice president of the Chinese Social Security Association, said, "it is expected to promote the reform of the medical and health system in an all-round way by turning" healthy China "into a national strategy Despite the bright prospect of the health industry, it is undeniable that there is still a certain gap between the reality and the goal in order to solve the problems of being able to see a doctor, being able to see a doctor, and being able to see a good doctor Hu Shanlian believes that no matter the reform of the medical field or the development of the health industry, we should devote ourselves to solving three things: first, solving the problem of medical equity; second, improving the quality of medical services Third, increase medical investment Li Bin, director of the national health and Family Planning Commission, once said on the 13th five year plan of the pharmaceutical industry: to build a healthy China, we should pay more attention to the downward shift of the focus of medical and health work and the sinking of resources Therefore, we should reduce the expenditure of people's medical treatment and solve the problem of waiting in line for 3 hours to see a doctor The problem of minutes will be the direction of pharmaceutical enterprises, who can focus on solving these problems, who can win the market and seize the development opportunity He pointed out that the strategic plan of "healthy China" will focus on human health, implement the strategy of "healthy China" and integrate into economic and social development from the perspective of big health, big health and big medicine, and achieve the goal of healthy development through comprehensive policies and measures.